Select Page
Responsive Centered YouTube Video
Discussion on the impact of COVID-19 on children and healthcare system, highlighting initial concerns and eventual stabilization.
  • Children were less impacted by COVID-19 compared to adults, leading to concerns about healthcare system capacity. 1:31

  • Retired pediatrician was psychologically prepared to return to frontline work during the pandemic. 3:15

  • Initial surreal atmosphere during the early stages of the pandemic. 5:20

  • Healthcare system faced challenges with increasing intensive care numbers and resource allocation. 5:41

  • Children’s ward was almost converted to an additional intensive care unit due to rising cases. 6:11

  • Diabetic children were avoiding hospital visits during the peak of the pandemic. 6:33

  • The situation eventually stabilized, leading to a decrease in pediatric cases and a return to normalcy. 6:45

  • Hospital resources were reallocated to address the surge in adult COVID-19 cases. 6:53

Discussion on the decision-making process regarding COVID-19 vaccination in children.
  • Initial guidance for over 70s to stay indoors for 12 weeks. 6:50

  • Variability in school reopening decisions during the pandemic. 7:16

  • Challenges in transitioning surgical theaters back to normal use. 8:06

  • Delay in catching up with medical backlogs due to pandemic disruptions. 8:25

  • Consideration of intentionally exposing children to achieve herd immunity. 8:37

  • Studies showing lower COVID-19 risk for teachers and healthcare workers with children. 9:32

  • Initial exclusion of children from vaccination program; surprise at children’s trial. 11:23

  • Assurance from vaccine expert on safety evaluation before child vaccination rollout. 11:50

  • Confirmation that COVID-19 vaccine rollout for children was not expected within a year. 12:13

Challenges faced by a group of scientists providing alternative viewpoints on COVID-19 vaccination in children were largely ignored by the government.
  • Dr. Ros Jones joined a group of scientists in January 2021 to provide a different perspective on COVID-19 data and advice. 15:03

  • The group included various experts such as pediatricians, ethicists, and public health consultants. 15:33

  • The group aimed to offer a balanced view of COVID-19 management, focusing on broader disciplines than the government’s advisory team. 15:40

  • Their efforts included analyzing the impacts of lockdowns, masks, and other measures on children’s well-being. 16:03

  • Despite sending weekly bulletins and position statements to MPs, the group’s advice was mostly ignored by central government. 16:38

  • The government may have viewed the group as a fringe opinion rather than a valuable source of advice. 17:34

  • The group also engaged in discussions regarding the ethics of COVID-19 vaccination in children with regulatory bodies like the MHRA and JCVI. 17:59

  • Science should involve open debate and discussion to prevent becoming dogmatic in its approach. 18:14

Challenges faced by medical professionals in speaking out against COVID-19 vaccine mandates and censorship.
  • Massive censorship and job loss for speaking out against COVID-19 measures. 18:22

  • Concerns about lack of informed consent and conflicts of interest in academia. 21:26

  • Fear and pressure leading to silence among medical professionals. 23:21

  • Vaccine mandates in NHS causing division among age groups. 23:54

Challenges in promoting COVID-19 vaccination discussed by a retired pediatrician.
  • Questioning the necessity of COVID-19 vaccination after natural immunity 24:18

  • Concerns about consistent messaging in public health vs. questioning procedures 24:24

  • Comparison of COVID-19 vaccine to traditional vaccines and its experimental nature 26:03

  • Deceptive tactics in promoting COVID-19 vaccination 26:28

  • Legal implications and coercion for COVID-19 vaccination in certain countries 27:26

  • Risk assessment for different age groups in relation to COVID-19 vaccination 28:32

  • Differences in technology and perception of COVID-19 vaccine compared to traditional vaccines 29:54

Ethical considerations and uncertainties surrounding COVID-19 vaccination in children.
  • mRNA technology is new and untested in humans 30:18

  • Uncertainty in dosage and antigen levels with mRNA vaccines 30:41

  • Concerns about biodistribution of lipid nanoparticles in the body 31:36

  • UK government acknowledges uncertainty in impact of vaccination for children 33:38

  • Focus on potential future waves rather than current COVID-19 situation 34:05

  • Consideration of wider implications such as education and missed school days 34:32

  • Questioning the necessity of vaccinating children based on school attendance 35:00

  • Low percentage of children actually contracting COVID-19 in school settings 35:38

  • Changes in isolation rules due to minimal transmission in school environments 36:06

Ethical concerns and risks associated with COVID-19 vaccination in children discussed by Dr. Ros Jones.
  • Schools not following guidelines on isolating children, causing unnecessary disruption. 36:12

  • Modeling on vaccination benefits did not consider children who had already had COVID-19. 36:39

  • Concerns raised about the psychological impact and side effects of vaccines in children. 37:39

  • Higher risk of myocarditis in adolescents after the second dose of Pfizer vaccine. 38:57

  • Data from Israel and Hong Kong show varying rates of myocarditis post-vaccination. 39:02

  • Hong Kong discontinued second doses due to higher risk of myocarditis. 40:16

  • Prediction of increased myocarditis cases in 12-15 year olds if given second dose. 40:33

  • Question raised on regulatory staff’s decision to vaccinate their own children. 41:06

  • Histopathological examination showing fibrosis in muscle post-vaccination in adolescents. 41:20

Concerns raised about the safety and necessity of COVID-19 vaccination in children.
  • Inflammatory process occurred before the second dose, leading to deaths within four days 41:39

  • High percentage of children showed evidence of heart muscle swelling and scarring post-vaccination 43:03

  • Urgent need for thorough follow-up studies on children post-vaccination 44:09

  • Risks of viral myocarditis in children and potential long-term implications 46:57

  • Caution urged in rushing vaccination efforts for children without sufficient data 47:09

Challenges in COVID-19 vaccination ethics and monitoring highlighted by a retired pediatrician.
  • COVID-19 vaccine safety concerns and adverse event reporting systems like VAERS and Yellow Card 47:43

  • Significant increase in adverse event reports, including deaths, related to COVID-19 vaccines 48:02

  • Emergency use authorization for vaccines in children questioned due to low risk 48:28

  • Influence of pressure from governments and pharmaceutical companies on decision-making 49:06

  • Conflict of interest issues within regulatory bodies and lack of separation from drug industry 50:01

  • Challenges in post-marketing surveillance and reporting of vaccine adverse events 51:36

  • Importance of proper age stratification in identifying vaccine-related adverse events 53:08

Ethical considerations and shortcomings in COVID-19 vaccination rollout for children discussed by Dr. Ros Jones.
  • Misquoted data on myocarditis risk post-COVID vs. post-vaccination, with age group variations. 53:46

  • Importance of informed consent tailored to individual risk factors and relevant information. 54:18

  • Concerns raised about potential long-term vaccine side effects being overlooked. 54:30

  • All-cause mortality as a crucial metric for assessing vaccine efficacy and safety. 55:06

  • Issue of excluding early adverse events from vaccine trial analyses. 55:24

  • Disconnect between physicians and vaccine administration settings impacting informed consent. 57:52

  • Transition from prioritizing vulnerable groups to achieving herd immunity timeline discussed. 57:52

  • Lack of awareness among vaccine administrators about potential side effects like myocarditis. 59:05

  • Concerns raised about underreporting or lack of vigilance for adverse events like myocarditis. 59:23

Ethical concerns and misinformation surrounding COVID-19 vaccination in children.
  • Lack of proper communication and awareness among healthcare professionals about myocarditis risk in young adults 59:37

  • Inadequate dissemination of information regarding vaccine risks and exemptions, leading to potentially harmful situations 1:00:03

  • Misleading reasons being given to parents for vaccinating children, such as protecting vulnerable relatives and facilitating work or travel 1:01:34

  • Emphasis on natural immunity in children and the effectiveness of their upper airway immunity, contrary to common misconceptions 1:03:30

  • Government misinformation regarding vaccine safety and the importance of natural immunity, contributing to public confusion 1:04:14

  • Evidence of long-term natural immunity against viruses like SARS-CoV-2 in children, highlighting the overlooked aspect of upper airway immunity 1:05:00

Importance of parental instincts in deciding on children's vaccinations amid missing public health advice.
  • Discussion on the oversight of mucosal upper airway immunity in decision-making. 1:05:20

  • Concerns raised about the lack of expert immunologists in decision-making processes. 1:05:36

  • Highlight on unlimited indemnity for drug companies in case of vaccine injuries. 1:06:00

  • Observations on the neglected public health advice regarding vitamin D supplementation. 1:08:00

  • Emphasis on the role of parental instincts in evaluating vaccination risks for children. 1:11:02

Discussion on protecting children during COVID-19 vaccination and the role of adults.
  • Reminder to trust instincts when safeguarding children 1:11:16

  • Importance of adults protecting children 1:11:24

  • Appreciation for informative and inspiring discussion 1:11:40

  • Outro thanking viewers and guest speaker 1:11:48